Huihan Wang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Developmental Neuroscience top 10%
Papers in
-
- Epigenetics and DNA Methylation 6
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 5
- Hematology 14
- Multiple Myeloma Research and Treatments 9
- Co-authors
- Zhuogang Liu (13 shared papers)Aijun Liao (12 shared papers)Yingchun Li (8 shared papers)Wei Yang (3 shared papers)Li Shen (4 shared papers)Fei Tian (3 shared papers)Xiaobin Wang (10 shared papers)Jiali Yu (3 shared papers)
- Journals
- Molecular and Cellular Biochemistry (3 papers)Frontiers in Oncology (3 papers)Annals of Translational Medicine (2 papers)Journal of Translational Medicine (2 papers)Frontiers in Nutrition (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Huihan Wang
62 papers receiving 938 citations
Peers
Comparison fields: 5 of 107
- Cancer Research 187
- Developmental Neuroscience 49
- Hematology 108
- Molecular Biology 620
- Toxicology 19
Countries citing papers authored by Huihan Wang
This map shows the geographic impact of Huihan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huihan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huihan Wang more than expected).
Fields of papers citing papers by Huihan Wang
This network shows the impact of papers produced by Huihan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huihan Wang. The network helps show where Huihan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Huihan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 109 | |
| 2 | 2017 | 100 | |
| 3 | 2020 | 79 | |
| 4 | 2015 | 60 | |
| 5 | 2012 | 56 | |
| 6 | 2010 | 39 | |
| 7 | 2019 | 33 | |
| 8 | 2022 | 31 | |
| 9 | 2021 | 26 | |
| 10 | 2020 | 25 | |
| 11 | 2024 | 25 | |
| 12 | 2021 | 23 | |
| 13 | 2017 | 23 | |
| 14 | 2017 | 17 | |
| 15 | 2012 | 16 | |
| 16 | 2023 | 15 | |
| 17 | [Study on mechanism of bortezomib inducing peripheral neuropathy and the reversing effect of reduced glutathione]. | 2011 | 14 |
| 18 | 2023 | 13 | |
| 19 | 2017 | 13 | |
| 20 | The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway. | 2012 | 13 |
About Huihan Wang
Huihan Wang is a scholar working on Molecular Biology, Hematology, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 66 papers that have together received 947 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (9 papers), Remote Sensing in Agriculture (7 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related molecular mechanisms research (6 papers), Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (187 citations), Developmental Neuroscience (49 citations), Hematology (108 citations), Molecular Biology (620 citations) and Toxicology (19 citations). Huihan Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhuogang Liu, Aijun Liao, Yingchun Li, Wei Yang, Li Shen, Fei Tian, Xiaobin Wang, Jiali Yu, Gang Pei and Wei Yang. Their work appears in journals such as Molecular and Cellular Biochemistry, Frontiers in Oncology, Annals of Translational Medicine, Journal of Translational Medicine and Frontiers in Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.